Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Oct 8;22(1):610.
doi: 10.1186/s12951-024-02863-0.

The new advance of exosome-based liquid biopsy for cancer diagnosis

Affiliations
Review

The new advance of exosome-based liquid biopsy for cancer diagnosis

Haozhou Tang et al. J Nanobiotechnology. .

Abstract

Liquid biopsy is a minimally invasive method that uses biofluid samples instead of tissue samples for cancer diagnosis. Exosomes are small extracellular vesicles secreted by donor cells and act as mediators of intercellular communication in human health and disease. Due to their important roles, exosomes have been considered as promising biomarkers for liquid biopsy. However, traditional methods for exosome isolation and cargo detection methods are time-consuming and inefficient, limiting their practical application. In the past decades, many new strategies, such as microfluidic chips, nanowire arrays and electrochemical biosensors, have been proposed to achieve rapid, accurate and high-throughput detection and analysis of exosomes. In this review, we discussed about the new advance in exosome-based liquid biopsy technology, including isolation, enrichment, cargo detection and analysis approaches. The comparison of currently available methods is also included. Finally, we summarized the advantages and limitations of the present strategies and further gave a perspective to their future translational use.

Keywords: Biomarker; Cancer; Diagnosis; Exosomes; Liquid biopsy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
New isolation and enrichment methods for exosomes. A. Separation based on acoustofluidic platform. B. Separation based on deterministic lateral displacement. C. Separation based on negative magnetophoretic technique. D. Viscoelasticity-based separation. E. Separation based on asymmetric-flow field-flow fractionation. F. Dielectrophoretic separation. G. Separation by magnetic beads modified with antibodies. H. Separation based on aptamer targeting surface proteins. I. Separation based on paper-based device. J. Nanowire-array-based separation. K. Phospholipid-based separation. L. Separation based on Tim4 beads targeting PS
Fig. 2
Fig. 2
Single exosome detection technology based on total internal reflection fluorescence (TIRF) imaging system
Fig. 3
Fig. 3
New technology for analyzing exosomal cargoes. A. Using electrochemical sensor to detect proteins. B. Using surface plasmon resonance or localized surface plasmon resonance biosensor to detect proteins. C. Protein detection based on surface enhanced raman spectra. D. Protein detection based on flow cytometry. E. Protein detection based on fluorescence signals. F. Nucleic acids detection based on CRISPR/Cas system. G. Nucleic acids detection based on drop digital PCR. H. Nucleic acids detection based on rolling circle amplification. I. Nucleic acids detection based on hairpin probes. J. Nucleic acids detection based on DNA polyhedral probes
None

Similar articles

Cited by

References

    1. Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. Cancer J Clin. 2023;73:17–48. - PubMed
    1. Shafritz DA, Shouval D, Sherman HI, Hadziyannis SJ, Kew MC. Integration of Hepatitis B Virus DNA into the genome of liver cells in Chronic Liver Disease and Hepatocellular Carcinoma. N Engl J Med. 1981;305:1067–73. - PubMed
    1. Heitzer E, Haque IS, Roberts CES, Speicher MR. Current and future perspectives of liquid biopsies in genomics-driven oncology. Nat Rev Genet. 2018;20:71–88. - PubMed
    1. Tie J, Cohen JD, Lahouel K, Lo SN, Wang Y, Kosmider S, Wong R, Shapiro J, Lee M, Harris S, et al. Circulating tumor DNA analysis guiding adjuvant therapy in stage II Colon cancer. N Engl J Med. 2022;386:2261–72. - PMC - PubMed
    1. Sparano J, O’Neill A, Alpaugh K, Wolff AC, Northfelt DW, Dang CT, et al. Association of circulating tumor cells with late recurrence of Estrogen receptor–positive breast Cancer. JAMA Oncol 2018;4:1700–6. - PMC - PubMed

Substances

LinkOut - more resources